-
- José R. Arribas
- Infectious Diseases Unit, Hospital Universitario La Paz-IdiPAZ, Madrid
-
- Sanjay Bhagani
- Department of Infectious Diseases, Royal Free Hospital, London
-
- Suzana M. Lobo
- Intensive Care Division, Hospital de Base, Faculdade de Medicina de São José do Rio Preto, Brazil
-
- Ilsiyar Khaertynova
- Republican Clinical Infectious Diseases Hospital n.a. A.F. Agafonov, Kazan, Russian Federation
-
- Lourdes Mateu
- Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Barcelona
-
- Roman Fishchuk
- Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivsk, Ukraine
-
- William Y. Park
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington/Valley Medical Center, Renton, WA
-
- Khetam Hussein
- Infection Control Unit, Rambam Healthcare Campus, Haifa, Israel
-
- Sei Won Kim
- Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Jade Ghosn
- Infectious and Tropical Diseases Department, Assistance Publique–Hôpitaux de Paris Bichat-Claude Bernard Hospital, Paris
-
- Michelle L. Brown
- Merck & Co., Inc, Kenilworth, NJ
-
- Ying Zhang
- Merck & Co., Inc, Kenilworth, NJ
-
- Wei Gao
- Merck & Co., Inc, Kenilworth, NJ
-
- Christopher Assaid
- Merck & Co., Inc, Kenilworth, NJ
-
- Jay A. Grobler
- Merck & Co., Inc, Kenilworth, NJ
-
- Julie Strizki
- Merck & Co., Inc, Kenilworth, NJ
-
- Mary Vesnesky
- Merck & Co., Inc, Kenilworth, NJ
-
- Amanda Paschke
- Merck & Co., Inc, Kenilworth, NJ
-
- Joan R. Butterton
- Merck & Co., Inc, Kenilworth, NJ
-
- Carisa De Anda
- Merck & Co., Inc, Kenilworth, NJ
収録刊行物
-
- NEJM Evidence
-
NEJM Evidence 1 (2), 2022-01-25
Massachusetts Medical Society